MMP-2 and 9 in Chronic Kidney Disease
AbstractGelatinases are members of the matrix metalloproteinase (MMPs) family; they play an important role in the degradation of the extracellular matrix (ECM). This effect is also crucial in the development and progression of chronic kidney disease (CKD). Its expression, as well as its activity regulation are closely related to the cell signaling pathways, hypoxia and cell membrane structural change. Gelatinases also can affect the development and progression of CKD through the various interactions with tumor necrosis factors (TNFs), monocyte chemoattractant proteins (MCPs), growth factors (GFs), oxidative stress (OS), and so on. Currently, their non-proteolytic function is a hot topic of research, which may also be associated with the progression of CKD. Therefore, with the in-depth understanding about the function of gelatinases, we can have a more specific and accurate understanding of their role in the human body. View Full-Text
Share & Cite This Article
Cheng, Z.; Limbu, M.H.; Wang, Z.; Liu, J.; Liu, L.; Zhang, X.; Chen, P.; Liu, B. MMP-2 and 9 in Chronic Kidney Disease. Int. J. Mol. Sci. 2017, 18, 776.
Cheng Z, Limbu MH, Wang Z, Liu J, Liu L, Zhang X, Chen P, Liu B. MMP-2 and 9 in Chronic Kidney Disease. International Journal of Molecular Sciences. 2017; 18(4):776.Chicago/Turabian Style
Cheng, Zhengyuan; Limbu, Manoj H.; Wang, Zhi; Liu, Jing; Liu, Lei; Zhang, Xiaoyi; Chen, Pingsheng; Liu, Bicheng. 2017. "MMP-2 and 9 in Chronic Kidney Disease." Int. J. Mol. Sci. 18, no. 4: 776.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.